Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
The addition of these executive team members will support the company’s continued growth and adoption of the innovative Sonata Treatment.
- The addition of these executive team members will support the company’s continued growth and adoption of the innovative Sonata Treatment.
- Commenting on these appointments, Skip Baldino, President and Chief Executive Officer of Gynesonics said, “I am very pleased to welcome Ted Stephens, Keith Chrzanowski, and Laurie Sandberg to Gynesonics.
- Their collective contributions will help further accelerate adoption of the Sonata Treatment and help deliver on our commitment to provide women with a safe, effective alternative to more invasive treatment options for symptomatic fibroids.”
Mr. Ted Stephens joins Gynesonics as its Chief Marketing and Strategy Officer. - Prior to joining Gynesonics he provided outstanding human resource and operational leadership to achieve success within several industries.